OurCrowd Portfolio Company Zebra Med Receives New FDA Clearance

OurCrowd portfolio company Zebra Medical Vision has received its third FDA clearance for its HealthICH product which is an AI alert for intracranial hemorrhage (ICH), based on head CT scans. The process is said to be the first of its kind.

The Zebra Med solution now provides alerts for both CT scans and X-rays, and currently addresses two acute conditions: intracranial hemorrhages (head CTs), and pneumothorax (chest X-rays), which also received FDA clearance in the past month. Additionally, the FDA cleared their calcium scoring product previously.

Zebra Med offers an AI1 or “all-in-one” bundle that provides hospitals with a AI tools at a fixed annual price.

Intracranial hemorrhage accounts for about 10% to 20% of all strokes, and can occur as a result of traumatic injury, ruptured arteries (aneurysms), stroke or cancer.

Regardless of the cause, the timely and accurate diagnosis of active bleeding is essential for the successful care of these patients. Intracranial hemorrhage is a devastating disease, with a high 30-day mortality rate that ranges from 35% to 52%. It is estimated that about 50% of this mortality occurs within the first 24 hours, emphasizing the importance of early detection and effective treatment in the ER.

Dr. Stanley Lu, MD, Radiologist and head of Neuroradiology at Monmouth Medical Center, part of RWJBarnabas Health explained they have deployed Zebra Medical Vision’s triage head CT solution that alerts their department of acute cases of intracranial hemorrhage.

“We have found the technology to be helpful as a second layer of analysis augmenting the clinical team’s detection and response time for acute cases.”

In busy ER environments, teleradiology services and other healthcare organizations that integrate Zebra-Med’s ‘All in one’ (AI1) solution, radiologists can address these prioritized scans in a timely manner.

Eyal Gura , Zebra-med’s CEO, said they were thrilled with the FDA news.

Zebra-Med was founded in 2014 by Gura, Eyal Toledano, and Elad Benjamin and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J, and Dolby Ventures. Zebra Medical Vision has raised $50 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company.


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!

Sponsored Links by DQ Promote

Send this to a friend